The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder
Top Cited Papers
- 23 September 2007
- journal article
- Published by Springer Nature in Nature Materials
- Vol. 6 (12) , 997-1003
- https://doi.org/10.1038/nmat2013
Abstract
A key tenet of bone tissue engineering is the development of scaffold materials that can stimulate stem cell differentiation in the absence of chemical treatment to become osteoblasts without compromising material properties. At present, conventional implant materials fail owing to encapsulation by soft tissue, rather than direct bone bonding. Here, we demonstrate the use of nanoscale disorder to stimulate human mesenchymal stem cells (MSCs) to produce bone mineral in vitro, in the absence of osteogenic supplements. This approach has similar efficiency to that of cells cultured with osteogenic media. In addition, the current studies show that topographically treated MSCs have a distinct differentiation profile compared with those treated with osteogenic media, which has implications for cell therapies.Keywords
This publication has 43 references indexed in Scilit:
- Measuring Cell Forces by a Photoelastic MethodBiophysical Journal, 2007
- Nanotopographical stimulation of mechanotransduction and changes in interphase centromere positioningJournal of Cellular Biochemistry, 2006
- Shear‐Stress Profile along a Cell Focal AdhesionAdvanced Materials, 2006
- Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experimentsPublished by Wiley ,2004
- Expression of ICAM-1 by osteoblasts in healthy individuals and in patients suffering from osteoarthritis and osteoporosisBone, 2004
- Patterns of gene expression in rat bone marrow stromal cells cultured on titanium alloy discs of different roughnessJournal of Biomedical Materials Research Part A, 2004
- Arrays of nano-dots for cellular engineeringMicroelectronic Engineering, 2003
- Induction of Human Osteoprogenitor Chemotaxis, Proliferation, Differentiation, and Bone Formation by Osteoblast Stimulating Factor-1/Pleiotrophin: Osteoconductive Biomimetic Scaffolds for Tissue EngineeringJournal of Bone and Mineral Research, 2003
- Optimizing HAPEX™ Topography Influences Osteoblast ResponseTissue Engineering, 2002
- Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotypeEndocrine Reviews, 1993